Quick Summary
- The company exceeded Q4 profit expectations with EPS of $1.90 versus the $1.71 consensus forecast, but forward guidance disappointed
- Fiscal 2027 EPS outlook of $11.20–$11.90 fell short of the $12.44 analyst consensus
- Beer division revenue increased 1% during Q4, while wine and spirits plunged 58% to $194.2 million
- Management aims to achieve over $200 million in annual expense reductions by fiscal year 2028
- New CEO Nicholas Fink assumes leadership on April 13, succeeding outgoing Bill Newlands
Despite surpassing fourth-quarter profit forecasts, Constellation Brands watched its shares decline as investors reacted negatively to underwhelming fiscal 2027 projections.
The beverage manufacturer reported quarterly earnings per share of $1.90 for the period ending February 28, comfortably ahead of the analyst consensus of $1.71. Revenue totaled $1.92 billion, representing an 11% decline from the previous year but still surpassing Wall Street’s $1.84 billion projection.
However, the earnings beat was overshadowed by weaker-than-anticipated forward guidance. The company projected fiscal 2027 EPS between $11.20 and $11.90, significantly trailing the Street’s $12.44 expectation. Additionally, management withdrew all fiscal 2028 projections, attributing the decision to ongoing economic headwinds and market volatility.
Constellation Brands, Inc., STZ
The beer division generated $1.73 billion in quarterly revenue, reflecting a marginal 1% uptick. Volume shipments climbed 1.1%, supported by favorable pricing strategies, though gains were partially neutralized by an adverse product mix.
Meanwhile, the wine and spirits segment painted a drastically different picture. Revenue plummeted 58% to just $194.2 million, fueled by a staggering 72.9% drop in shipment volumes. Management attributed the decline to portfolio divestitures, distributor agreement modifications, and deliberate pricing adjustments.
For the complete fiscal 2026 year, the company delivered EPS of $11.82 on revenues of $9.14 billion—a 10% year-over-year decrease but still exceeding internal guidance of $11.30–$11.60.
Industry Headwinds Mount
Consumer appetite for alcoholic beverages has remained subdued across multiple years. Economic volatility has discouraged restaurant and bar visits, while growing wellness trends have contributed to declining alcohol consumption across the industry.
Constellation faces unique challenges stemming from reduced spending among Hispanic consumers, who represent approximately half of its beer customer demographic. Evolving immigration policies throughout fiscal 2026 dampened confidence within this critical consumer segment.
During the first nine months of fiscal 2026, beer revenue contracted 4% compared to the prior year. Organic wine and spirits sales, excluding divestiture impacts, declined 16% across the same timeframe.
Bank of America maintained its Underperform rating on the stock, anticipating negative market sentiment. Morgan Stanley analyst Dara Mohsenian characterized the guidance as “seemingly conservative,” predicting the shares would surrender some recent relative gains.
Restructuring Efforts and Executive Transition
The company has been diversifying into higher-growth segments, including hard seltzer and non-alcoholic beverage categories. Last year, management initiated a comprehensive organizational restructuring with plans to eliminate more than $200 million in annual operating expenses by fiscal 2028.
On the executive front, board member Nicholas Fink—who joined the board in 2021—officially assumes the President and CEO position on April 13. Current CEO Bill Newlands, who has led the company since 2019, will retire but continue serving in an advisory capacity throughout the transition.
Some Wall Street analysts remain cautiously optimistic about near-term catalysts. Roth Capital Partners observed accelerating retail velocity for Constellation’s brands in recent weeks, while the upcoming World Cup could boost beer consumption during the summer months.
Year-to-date, STZ shares have advanced 8.9%, though they remain approximately 18% lower over the trailing twelve-month period.
